3-Chlor-5,5-dimethyl-2,4-hexandion | 41564-69-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Chlor-5,5-dimethyl-2,4-hexandion
• 英文别名: 3-Chlor-5,5-dimethylhexan-2,4-dion；3-Chloro-5,5-dimethyl-2,4-hexanedione；3-chloro-5,5-dimethylhexane-2,4-dione
• CAS: 41564-69-6
• 化学式: C₈H₁₃ClO₂
• 分子量: 176.643
• InChiKey: ZDIVJEIZOFVBOT-UHFFFAOYSA-N

物化性质

• 沸点：
  67-69 °C(Press: 1.5 Torr)
• 密度：
  1.060±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Chlor-5,5-dimethyl-2,4-hexandion 生成 [1-chloro-1-(4-chlorophenylhydrazono)]-3,3-dimethyl-2-butanone
  参考文献：
  名称：

  EP1935874

  摘要：

  公开号：
• 作为产物：
  描述：

  5,5-二甲己烷2,4-二酮 在 三甲基氯硅烷 、 四丁基溴化铵 、 二甲基亚砜 作用下， 以 乙腈 为溶剂， 以75 %的产率得到3-Chlor-5,5-dimethyl-2,4-hexandion
  参考文献：
  名称：

  使用 PET 合成、放射合成和生化评价 1-磷酸鞘氨醇受体 3 特异性拮抗剂的氟化类似物

  摘要：

  1-磷酸鞘氨醇及其受体 (S1PR) 与多种疾病有关，例如自身免疫、炎症和心血管疾病。 S1P 类似物芬戈莫德 (Gilenya®) 目前用于治疗复发性多发性硬化症。 S1PR 也是临床分子成像的有希望的目标。单个 S1PR 的器官分布可以通过使用 S1PR 亚型特异性（放射性标记）化学探针来实现。在这里，我们报告了基于 S1P 拮抗剂 TY-52156 的 S1P 受体 3 (S1P) 新配体的合成和效力测定，以及在 F 标记后使用正电子发射断层扫描 (PET) 验证潜在成像示踪剂的工作。 A-氟苯基衍生物表现出优异的S1P拮抗活性、良好的血清稳定性和中等的亲脂性。使用 F-PET 的生物分布实验显示出心肌的显着吸收，表明其在心脏成像中的潜在应用。

  DOI：

  10.1016/j.bmc.2024.117697

文献信息

• Pyrazole derivatives
  申请人：——

  公开号：US20030100554A1

  公开（公告）日：2003-05-29

  This invention relates to pyrazole derivatives of formula (I) 1 or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).

  这项发明涉及式(I)1的吡唑衍生物或药学上可接受的盐、溶剂合物或衍生物，以及其制备方法、用于其制备的中间体、含有它们的组合物和这些衍生物的用途。本发明的化合物与酶逆转录酶结合，并且是其调节剂，特别是其抑制剂。因此，本发明的化合物在治疗各种疾病方面具有用途，包括那些涉及逆转录酶抑制的疾病。感兴趣的疾病包括由人类免疫缺陷病毒（HIV）和遗传相关逆转录病毒引起的疾病，如获得性免疫缺陷综合症（AIDS）。
• 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
  申请人：Ladouceur H. Gaetan

  公开号：US20050119489A1

  公开（公告）日：2005-06-02

  Disclosed are 4-sulfide/sulfoxide/sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II): wherein the variables n, R, R 1 , R 2 , R 3 , R 3′ , R 4 , R 4′ , R 5 and R 6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT 2C receptor.

  本文揭示了公式（I）或（II）的4-硫/亚硫/磺酰基-1H-吡唑基衍生物化合物，其中变量n，R，R1，R2，R3，R3'，R4，R4'，R5和R6如规范中所定义。这些化合物可用于治疗或预防涉及5-HT2C受体的疾病和/或行为。
• Pyrazole Derivatives
  申请人：Jones Lyn Howard

  公开号：US20120029192A1

  公开（公告）日：2012-02-02

  This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).

  本发明涉及式（I）的吡唑衍生物或其药学上可接受的盐，溶剂或衍生物，以及其制备方法，用于制备中间体的组合物和这些衍生物的用途。本发明的化合物结合酶逆转录酶并且是调节剂，特别是抑制剂。因此，本发明的化合物在治疗包括逆转录酶抑制剂在内的多种疾病方面是有用的。感兴趣的疾病包括由人类免疫缺陷病毒（HIV）和遗传相关逆转录病毒引起的疾病，例如获得性免疫缺陷综合症（AIDS）。
• S1P3 RECEPTOR ANTAGONIST
  申请人：Ohnuma Shin-ya

  公开号：US20090170895A1

  公开（公告）日：2009-07-02

  The present invention relates to a medicine, and more particularly to novel arylamidrazone derivatives having an antagonistic action against S1P 3 receptors and a medicine containing thereof as an active ingredient. The present invention provides an arylamidrazone derivative represented by the following formula (1) or a pharmaceutically acceptable salt thereof: wherein R 1 represents a C 2 -C 8 alkyl group which may be substituted, a phenyl group which may be substituted, an aromatic heterocyclic group which may be substituted, a C 2 -C 8 alkoxy group which may be substituted, or —NR 4 R 5 (wherein R 4 and R 5 , which are identical or different, each represent a hydrogen atom or a lower alkyl group which may be substituted, or R 4 and R 5 may be joined with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic ring which may be substituted); R 2 and R 3 , which are identical or different, each represent a hydrogen atom, a halogen atom, a halo-lower alkyl group, a lower alkyl group, a lower alkynyl group, a lower alkoxy group, a cyano group, a lower alkanoyl group or a lower alkylsulfonyl group; A represents a benzene ring or a heterocyclic ring; D represents a single bond or methylene; m represents an integer from 1 to 3, and n represents an integer from 1 to 5 (with the proviso that the case where R 1 is an ethoxy group, R 2 is a 2,4-dichloro group, R 3 is a hydrogen atom, A is a benzene ring, and D is methylene; and the case where R 1 is an ethoxy group, R 2 is a 2,4-dichloro group, R 3 is a hydrogen atom, a 2-methyl group, a 4-methyl group, a 4-methoxy group or a 4-ethoxy group, A is a benzene ring, and D is a single bond, are excluded).

  本发明涉及一种药物，更具体地涉及一种对S1P3受体具有拮抗作用的新型芳基酰胺脲衍生物及其作为活性成分的药物。本发明提供了下式（1）或其药学上可接受的盐所表示的芳基酰胺脲衍生物：其中R1表示可取代的C2-C8烷基，可取代的苯基，可取代的芳香杂环基，可取代的C2-C8烷氧基，或—NR4R5（其中R4和R5相同或不同，每个代表氢原子或可取代的低烷基，或R4和R5可以与相邻的氮原子连接形成可取代的含氮杂环环，其中R4和R5的情况下，它们相邻的氮原子可以连接形成可取代的含氮杂环环）；R2和R3相同或不同，每个代表氢原子，卤原子，卤代低烷基，低烷基，低炔基，低烷氧基，氰基，低烷酰基或低烷基磺酰基；A代表苯环或杂环环；D代表单键或亚甲基；m表示1到3的整数，n表示1到5的整数（但其中R1为乙氧基，R2为2,4-二氯基，R3为氢原子，A为苯环，D为亚甲基的情况和R1为乙氧基，R2为2,4-二氯基，R3为氢原子，2-甲基，4-甲基，4-甲氧基或4-乙氧基，A为苯环，D为单键的情况不包括在内）。
• PYRAZOLE DERIVATIVES
  申请人：JONES Lyn Howard

  公开号：US20090215712A1

  公开（公告）日：2009-08-27

  This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereofs, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodeficiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).

  本发明涉及式（I）的吡唆烷衍生物或其药学上可接受的盐、溶剂或衍生物，其中R1到R4在描述中定义，并涉及其制备方法、制备中使用的中间体、含有它们的组合物以及这些衍生物的用途。本发明化合物与酶反转录酶结合，并且是调节剂，特别是抑制剂。因此，本发明化合物在治疗多种疾病中有用，包括那些与反转录酶抑制有关的疾病。感兴趣的疾病包括由人类免疫缺陷病毒（HIV）和遗传相关的逆转录病毒引起的疾病，如获得性免疫缺陷综合症（AIDS）。